Adaptimmune Therapeutics (ADAP) will resume trading at 4:35pm ET
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/16/2024
- Wall Street stocks mixed on higher Treasury yields, rate expectations
- Powell says recent inflation data point to need to keep rates higher for longer
- UnitedHealth (UNH) beats earnings, revenue estimates in Q1; shares up
- Bank of America profit hurt by losses on credit cards, office loans
- Morgan Stanley (MS) earnings beat lifts stock
- Trump Media & Technology Group (DJT) Files S-1
- Tesla (TSLA) Senior VP Drew Baglino Is Said To Leave The Company - Bloomberg
- GE HealthCare (GEHC) Announces Resignation of Jan Makela, CEO of Imaging
- General Motors (GM) Said to be Moving Detroit HQ to Dan Gilbert's Hudson Tower - Bloomberg
- Biohaven Pharma (BHVN) presents update on degrader platform and summary of progress to date in Phase 1 single ascending dose study for BHV-1300
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
- After-hours movers: Tesla, Gildan Activewear, Macatawa Bank, and more
- Midday movers: Goldman Sachs and Meta Platforms rise; Apple and Tesla fall
- Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall
Adaptimmune Therapeutics (ADAP) Tops Q3 EPS by 2c
November 10, 2016 6:33 AM ESTAdaptimmune Therapeutics (NASDAQ: ADAP) reported Q3 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $5.32 million.
For earnings history and earnings-related data on Adaptimmune Therapeutics (ADAP) click here.
... MoreAdaptimmune Therapeutics (ADAP), Novavax (NVAX) trading halted with news pending.
November 9, 2016 4:01 PM ESTAdaptimmune Therapeutics (NASDAQ: ADAP), Novavax (NASDAQ: NVAX) trading halted with news pending.
... More
